Results 11 to 20 of about 138,093 (211)
Research exploring the integration of pharmacogenomics (PGx) testing by pharmacists into their primary care practices (including community pharmacies) has focused on the “external” factors that impact practice implementation.
Miles J. Luke +9 more
doaj +1 more source
Background Implementing new practices requires changes in the behaviour of relevant actors, and this is facilitated by understanding of the determinants of current and desired behaviours.
Lou Atkins +11 more
doaj +1 more source
Background Interventions to improve personalised and holistic care delivery by healthcare professionals are more likely to be effective if they target the factors influencing specific behaviours.
Eunice Wong +4 more
doaj +1 more source
Background Prescribing errors are a major source of morbidity and mortality and represent a significant patient safety concern. Evidence suggests that trainee doctors are responsible for most prescribing errors.
Duncan Eilidh M +10 more
doaj +1 more source
Background Longstanding variation in the views of family physicians (FPs) on the role of opioids seems to translate into widely varying prescribing rates.
L. Desveaux +3 more
doaj +1 more source
Introduction Long‐term benzodiazepine receptor agonist (BZRA) use persists in healthcare settings worldwide and poses risks of patient harm. Objective This study aimed to develop an intervention to support discontinuation of long‐term BZRA use among ...
Tom Lynch +8 more
doaj +1 more source
Background Over-occupancy at the two tertiary pediatric care hospitals in Alberta, Canada is steadily increasing with simultaneous decline in occupancy of pediatric beds at regional hospitals. Over-occupancy negatively impacts timeliness and potentially,
Sumedh Bele +5 more
doaj +1 more source
Background Preventative inhaled treatments preserve lung function and reduce exacerbations in cystic fibrosis (CF). Self-reported adherence to these treatments is over-estimated.
Carla Girling +5 more
doaj +1 more source
Background Implementing the treatment arm of a clinical trial often requires changes to healthcare practices. Barriers to such changes may undermine the delivery of the treatment making it more likely that the trial will demonstrate no treatment effect ...
Justin Presseau +8 more
doaj +1 more source
Background People with HIV (PWH) experience increased cardiovascular disease (CVD) risk. Many PWH in the USA receive their primary medical care from infectious disease specialists in HIV clinics.
Julie Schexnayder +11 more
doaj +1 more source

